United States Antimony Corporation faces intensified downside pressure as critical production setbacks surface while stocks have been trading down by -19.31 percent
Click Here for a Millionaire's POV on Trading UAMY
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Fiscal 2026 revenue guidance was cut to $60M–$75M from $125M, far below the roughly $115M Street view and signaling a major downgrade to growth expectations.
- Q2 revenue of $7.9M came in miles under the $21.7M consensus, showing United States Antimony’s challenges are already hitting the income statement.
- Management blamed weak antimony prices, delayed DLA contract deliveries, and slower production ramp-ups even as it stressed long-term demand and future capacity additions.
- UAMY also reduced its 2026 gross revenue forecast by roughly half versus prior guidance, reinforcing a sharp reset in the company’s near-term earnings power.
Live Update At 09:17:28 EDT: On Wednesday, August 12, 2026 United States Antimony Corporation stock [NYSE: UAMY] is trending down by -19.31%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
United States Antimony Corporation, ticker UAMY, just delivered the sort of reset that shakes a chart from trend to turning point. On the surface, the recent daily candles looked constructive. UAMY climbed from about $5.07 on 2026/07/31 to the $6.58 area by 2026/08/11, with a strong push through $6.00 and several higher closes. That’s a solid near‑30% run in less than two weeks, the kind of move momentum traders hunt.
Intraday, the 5‑minute tape shows UAMY trading in a tight band around $5.30–$5.70 earlier in the session, with liquidity but no wild spikes. That usually signals two camps: shorts leaning on the news and dip‑buyers waiting for a clear level to defend.
Under the hood, though, the fundamentals look heavy. UAMY is running negative margins across the board, with an EBIT margin of about -41% and a profit margin near -41%. Return on equity and return on assets are both negative, while the price‑to‑sales ratio sits lofty around 25. That means traders are paying a rich multiple for a business that’s still losing money.
More Breaking News
- NOK Stock Rallies As AI Orders And FCC Tailwinds Fuel Momentum
- ITUB Stock Slips As Momentum Stalls Near Recent Range Highs
- EOSE Stock Jumps As Defense Deals And Backlog Explode
- HYLN Stock Rallies As Navy KARNO Deal Fuels Outlook
Yes, United States Antimony has a strong balance sheet on paper — plenty of cash, no real net debt, and a current ratio around 3.6 — but cash burn is real, with free cash flow deep in the red. For traders, that mix of extended valuation, weak earnings, and fresh guidance cuts sets the stage for volatility and sharp, tradeable swings in UAMY.
Why Traders Are Watching UAMY After The Guidance Cut
When a small‑cap commodity name like UAMY takes a machete to guidance, traders pay attention. United States Antimony didn’t just tweak numbers; it slashed fiscal 2026 revenue guidance to $60M–$75M from $125M. That new range also lands far below the roughly $115M consensus, which means the Street’s growth story around UAMY has to be rewritten almost from scratch.
The company tied this reset to three main issues: a steep drop in antimony prices, delayed Defense Logistics Agency contract deliveries related to capacity expansion at Thompson Falls, and a slower production and shipment ramp. Translation for traders: the macro backdrop turned against UAMY at the same time execution hit speed bumps.
This isn’t just about the future. The latest Q2 print showed revenue of only $7.9M versus expectations around $21.7M, and management acknowledged that both revenue and net income fell year over year while badly missing analyst estimates. On top of that, United States Antimony cut its broader 2026 gross revenue forecast by roughly half compared with prior guidance.
When a company like UAMY slices its outlook in half, valuation models get torched. That usually pressures the share price as analysts update numbers and momentum algos pick up the trend. At the same time, these are the types of broken‑expectation stories that experienced traders in the Sykes community track closely. If selling gets overdone, UAMY can become a classic bounce candidate. If support fails, it can turn into a clean short around failed bounces and resistance levels.
Either way, the violence of this reset is why UAMY sits on many watchlists right now.
Conclusion
For active traders, UAMY is shifting from a quiet materials play to a live‑wire story stock. United States Antimony has cash, working capital, and capacity expansion plans, but the latest Q2 miss and the brutal fiscal 2026 guide‑down change how the market views near‑term earnings power. A revenue range of $60M–$75M versus prior $125M guidance — and versus about $115M consensus — resets expectations sharply lower.
On the chart, UAMY’s recent run into the mid‑$6s now meets a wall of bad news. That mix can produce fast moves in both directions. Breakdowns below recent support may attract short‑biased traders, while panic flushes can draw in dip‑buyers looking for quick, oversold bounces. The key is to trade the price action, not fall in love with the United States Antimony story.
This is exactly the kind of setup Tim Sykes talks about when he says, “Discipline and risk management are everything — you’re only as good as your last trade.” It also echoes the emphasis on process that many trading educators stress. As Tim Bohen, lead trainer with StocksToTrade says, “A consistent trading routine beats sporadic action every time. Show up daily, and you’ll start to see the patterns others miss.”. For anyone trading UAMY, that means tight plans, hard stops, and a clear focus on intraday levels. United States Antimony is now a catalyst‑driven name, and until guidance stabilizes, the only constant around this ticker is likely to be volatility.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.